Neoadjuvant Exisulind in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage II or Stage III Prostate Cancer

NCT00078910 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

130

Enrollment

NIH

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: exisulind
PROCEDURE: conventional surgery
PROCEDURE: neoadjuvant therapy

Sponsor

National Cancer Institute (NCI)